U.S. Securities and Exchange Commission (SEC)
Official Release: https://www.sec.gov/files/litigation/admin/2026/34-106326.pdf
NEWS:
The SEC's September 10, 2026 order, Release No. 34-106326, names China Health Industries Holdings, Inc. as the respondent in a proceeding under Section 12(j) of the Securities Exchange Act. The order identifies the issuer as a Delaware corporation located in Zhuhai City, Guangdong Province, China. It says the company has not filed a periodic report since its Form 10-Q for the period ended March 31, 2024.
The SEC alleges that the company repeatedly failed to meet its reporting obligations and did not respond to a delinquency letter from the Division of Corporation Finance—or may not have received it because it did not maintain a valid address on file. The order states that unsolicited quotations for the company's common stock, ticker CHHE, are submitted on OTC Link ATS.
The proceeding will allow the company to answer the allegations and present defenses. The SEC will consider whether to suspend the registration of its securities for up to 12 months or revoke that registration. These are allegations in an instituted proceeding, not a final determination that the company violated the reporting requirements.
KEY POINTS:
- SEC Release No. 34-106326, administrative file No. 3-22711, is dated September 10, 2026.
- The SEC alleges China Health Industries has not filed periodic reports since its March 31, 2024 Form 10-Q.
- The order identifies the company as a Delaware corporation based in Zhuhai City, China; its common stock ticker is CHHE.
- The alleged reporting violations concern Exchange Act Section 13(a) and Rules 13a-1 and 13a-13.
- Possible outcomes include suspension for up to 12 months or revocation of the securities' registration; the proceeding is pending.